Moreover, by modulating TGF‐β signaling pathway in 3D prostate cancer tumoroids (PCTs), established from patient samples, we revealed an interplay between TGF‐β expression and ECM accumulation and remodeling in primary prostate cancer. This evidence concerns the gene TGFB1 and prostate carcinoma.